Zimmer Biomet Holdings Inc
ZBH90.805USD
+0.275+0.30%
Close 12/30, 16:00（ET）Quotes delayed by 15 min
18.00BMarket Cap
22.40P/E TTM
More Details of Zimmer Biomet Holdings Inc Company
Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
Zimmer Biomet Holdings Inc Info
Ticker SymbolZBH
Company nameZimmer Biomet Holdings Inc
IPO dateJul 25, 2001
CEOTornos (Ivan)
Number of employees17000
Security typeOrdinary Share
Fiscal year-endJul 25
Address345 E Main St
CityWARSAW
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code46580-2746
Phone15742676131
Websitehttps://www.zimmerbiomet.com/en
Ticker SymbolZBH
IPO dateJul 25, 2001
CEOTornos (Ivan)
Company Executives of Zimmer Biomet Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
54.75K
+12.08%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
18.42K
-6.11%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
6.79K
--
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Mr. Syed A. Jafry
Mr. Syed A. Jafry
Independent Director
Independent Director
4.06K
--
Mr. Robert A. Hagemann
Mr. Robert A. Hagemann
Independent Director
Independent Director
4.00K
--
Mr. Paul A. Stellato
Mr. Paul A. Stellato
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
3.42K
+34.66%
Mr. Arthur J. (Art) Higgins
Mr. Arthur J. (Art) Higgins
Independent Director
Independent Director
3.40K
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
54.75K
+12.08%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
18.42K
-6.11%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
6.79K
--
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Knees
826.00M
39.76%
S E T
550.60M
26.51%
Hips
536.10M
25.81%
Other product category
164.60M
7.92%
By RegionUSD
Name
Revenue
Proportion
United States
1.17B
56.51%
International
903.50M
43.49%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Knees
826.00M
39.76%
S E T
550.60M
26.51%
Hips
536.10M
25.81%
Other product category
164.60M
7.92%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Dodge & Cox
11.71%
The Vanguard Group, Inc.
11.70%
T. Rowe Price Associates, Inc.
7.46%
BlackRock Institutional Trust Company, N.A.
5.58%
State Street Investment Management (US)
4.36%
Other
59.19%
Shareholders
Shareholders
Proportion
Dodge & Cox
11.71%
The Vanguard Group, Inc.
11.70%
T. Rowe Price Associates, Inc.
7.46%
BlackRock Institutional Trust Company, N.A.
5.58%
State Street Investment Management (US)
4.36%
Other
59.19%
Shareholder Types
Shareholders
Proportion
Investment Advisor
54.12%
Investment Advisor/Hedge Fund
37.70%
Hedge Fund
2.18%
Pension Fund
2.06%
Research Firm
1.73%
Bank and Trust
1.28%
Sovereign Wealth Fund
1.27%
Individual Investor
0.13%
Family Office
0.07%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
1945
195.45M
98.66%
-607.37K
2025Q2
1996
190.39M
96.22%
-5.04M
2025Q1
2047
189.51M
95.78%
-9.49M
2024Q4
2042
186.55M
93.71%
-18.21M
2024Q3
1986
185.93M
91.29%
-23.02M
2024Q2
1982
190.82M
92.76%
-16.12M
2024Q1
1974
190.22M
92.57%
-13.55M
2023Q4
1991
188.03M
89.99%
-18.28M
2023Q3
1984
188.24M
90.09%
-20.30M
2023Q2
2003
190.89M
91.52%
-16.92M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Dodge & Cox
22.10M
11.15%
+2.01M
+10.01%
Jun 30, 2025
The Vanguard Group, Inc.
23.16M
11.69%
+196.58K
+0.86%
Jun 30, 2025
T. Rowe Price Associates, Inc.
14.50M
7.32%
+336.36K
+2.37%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
10.93M
5.52%
-195.19K
-1.75%
Jun 30, 2025
State Street Investment Management (US)
8.75M
4.42%
-6.59K
-0.08%
Jun 30, 2025
Capital International Investors
6.77M
3.42%
+6.77M
--
Jun 30, 2025
Geode Capital Management, L.L.C.
5.12M
2.59%
+69.48K
+1.37%
Jun 30, 2025
American Century Investment Management, Inc.
5.71M
2.88%
+458.90K
+8.74%
Jun 30, 2025
Harris Associates L.P.
3.73M
1.88%
+3.73M
--
Jun 30, 2025
PRIMECAP Management Company
4.71M
2.38%
+27.86K
+0.59%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Langar Global HealthTech ETF
4.98%
VanEck Morningstar Wide Moat Value ETF
4.58%
Leatherback Long/Short Alternative Yield ETF
2.9%
VanEck Morningstar Wide Moat ETF
2.46%
iShares U.S. Medical Devices ETF
2.37%
First Trust Indxx Medical Devices ETF
2.13%
American Century Focused Large Cap Value ETF
2.03%
Invesco Raymond James SB-1 Equity ETF
1.87%
First Trust Health Care Alphadex Fund
1.78%
State Street SPDR S&P Health Care Equipment ETF
1.75%
View more
Langar Global HealthTech ETF
Proportion4.98%
VanEck Morningstar Wide Moat Value ETF
Proportion4.58%
Leatherback Long/Short Alternative Yield ETF
Proportion2.9%
VanEck Morningstar Wide Moat ETF
Proportion2.46%
iShares U.S. Medical Devices ETF
Proportion2.37%
First Trust Indxx Medical Devices ETF
Proportion2.13%
American Century Focused Large Cap Value ETF
Proportion2.03%
Invesco Raymond James SB-1 Equity ETF
Proportion1.87%
First Trust Health Care Alphadex Fund
Proportion1.78%
State Street SPDR S&P Health Care Equipment ETF
Proportion1.75%
Dividend
A total of
996.70M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Dec 17, 2025
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 30, 2026 going ex on Dec 30, 2025 with reinvestment option
Dec 30, 2025
Jan 30, 2026
Dec 30, 2025
Aug 27, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2025 going ex on Sep 30, 2025 with reinvestment option
Sep 30, 2025
Oct 31, 2025
Sep 30, 2025
May 30, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2025 going ex on Jun 26, 2025
Jun 26, 2025
Jul 31, 2025
Jun 26, 2025
Feb 26, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2025 going ex on Mar 31, 2025
Mar 31, 2025
Apr 30, 2025
Mar 31, 2025
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024 with reinvestment option
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Aug 29, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2024 going ex on Sep 30, 2024 with reinvestment option
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 13, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2024 going ex on Jun 26, 2024 with reinvestment option
Jun 26, 2024
Jul 31, 2024
Jun 26, 2024
Feb 21, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 14, 2023
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 31, 2024
Dec 26, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Zimmer Biomet Holdings Inc?
The top five shareholders of Zimmer Biomet Holdings Inc are:
Dodge & Cox holds 22.10M shares, accounting for 11.15% of the total shares.
The Vanguard Group, Inc. holds 23.16M shares, accounting for 11.69% of the total shares.
T. Rowe Price Associates, Inc. holds 14.50M shares, accounting for 7.32% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 10.93M shares, accounting for 5.52% of the total shares.
State Street Investment Management (US) holds 8.75M shares, accounting for 4.42% of the total shares.
Dodge & Cox holds 22.10M shares, accounting for 11.15% of the total shares.
The Vanguard Group, Inc. holds 23.16M shares, accounting for 11.69% of the total shares.
T. Rowe Price Associates, Inc. holds 14.50M shares, accounting for 7.32% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 10.93M shares, accounting for 5.52% of the total shares.
State Street Investment Management (US) holds 8.75M shares, accounting for 4.42% of the total shares.
What are the top three shareholder types of Zimmer Biomet Holdings Inc?
The top three shareholder types of Zimmer Biomet Holdings Inc are:
Dodge & Cox
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.
Dodge & Cox
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.
How many institutions hold shares of Zimmer Biomet Holdings Inc (ZBH)?
As of 2025Q3, 1945 institutions hold shares of Zimmer Biomet Holdings Inc, with a combined market value of approximately 195.45M, accounting for 98.66% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 2.44%.
What is the biggest source of revenue for Zimmer Biomet Holdings Inc?
In FY2025Q2, the Knees business generated the highest revenue for Zimmer Biomet Holdings Inc, amounting to 826.00M and accounting for 39.76% of total revenue.
